# FDA Inspection 1280551 - Jiangxi Fushine Pharmaceutical Co., Ltd. - August 14, 2025

Source: https://www.globalkeysolutions.net/records/fda_inspections/jiangxi-fushine-pharmaceutical-co-ltd/deed8f0c-38f0-4057-a6b6-32c1796fd10a
Source feed: FDA_Inspections

> FDA Inspection 1280551 for Jiangxi Fushine Pharmaceutical Co., Ltd. on August 14, 2025. Classification: Voluntary Action Indicated (VAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1280551
- Company Name: Jiangxi Fushine Pharmaceutical Co., Ltd.
- Inspection Date: 2025-08-14
- Classification: Voluntary Action Indicated (VAI)
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1280551 - 2025-08-14](https://www.globalkeysolutions.net/records/fda_inspections/jiangxi-fushine-pharmaceutical-co-ltd/4646763e-feb9-4289-928d-ce7df0e4a3ed)
- [FDA Inspection 1084105 - 2019-01-18](https://www.globalkeysolutions.net/records/fda_inspections/jiangxi-fushine-pharmaceutical-co-ltd/730c7bc5-2424-4e39-8fd2-ae754635a6fc)
- [FDA Inspection 892989 - 2014-07-04](https://www.globalkeysolutions.net/records/fda_inspections/jiangxi-fushine-pharmaceutical-co-ltd/91dfa89d-cc02-436b-9ba4-47be6301d299)

Company: https://www.globalkeysolutions.net/companies/jiangxi-fushine-pharmaceutical-co-ltd/f0251298-6a25-4056-b1e7-2db2b106b608

Office: https://www.globalkeysolutions.net/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c
